Chantal Morel
Health economist in anti-microbial resistance, KPM Center for Public Management, University of Bern
Dr Chantal Morel is a health economist specializing in infectious diseases, and in the economic issues related to antimicrobial resistance in particular. Her research focusses on the use of systemic incentives to bolster innovation in the antibiotic pipeline, improve surveillance of resistance, support antibiotic stewardship (amongst humans and in agriculture), and increase access to antibiotics where clinical need is currently unmet by supply. This includes much emphasis on the dynamics within key health technology markets, including for anti-infectives, diagnostics, and vaccines.